Titan Pharma (India ) Private Limited, a active private limited company, was established on 10 September 2001 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24234MH2001PTC133316. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.38 M.
It upholds a compliant status. Its leadership includes Deepak Bhailal Shah (Director), Piyush Bhailal Shah (Director). Past directors included Hiromi Deepak Shah, Anil Virendra Shah. It holds no open charges and ₹7.09 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 210Awing,Kanarabusinesscentre,Behindeverestgradenbuilding,Laxminagar,Ghatkopar, (East),, Mumbai, Maharashtra, 400075.
U24234MH2001PTC133316
133316
10 September 2001
₹0.50 M
₹0.38 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Titan Pharma (India ) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Bhailal Shah | Director | 09 Oct 2001 | Current |
| Piyush Bhailal Shah | Director | 09 Oct 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Dec 2021 | Past |
| Pramod Abcsdd | Director | 24 Apr 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Titan Pharma (India ) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.62% increase. The company also saw a substantial improvement in profitability, with a 13.22% increase in profit. The company's net worth moved up by a moderate rise of 9.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Titan Pharma (India )'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹70,877,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2005 | Union Bank Of India | ₹6.74 Cr | Satisfied |
| 31 May 2004 | Union Bank Of India | ₹1.50 M | Satisfied |
| 02 May 2002 | Union Bank Of India | ₹1.00 M | Satisfied |
| 02 May 2002 | Union Bank Of India | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Titan Pharma (India ), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Titan Pharma (India ), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Titan Pharma (India )'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Titan Pharma (India ) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Titan Pharma (India ) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on A charge registered on 05 Aug 2005 via Charge ID 80028767 with Union Bank Of India was fully satisfied on 17 Sep 2013. was documented.
Progress on A charge registered on 31 May 2004 via Charge ID 90145203 with Union Bank Of India was fully satisfied on 17 Sep 2013. was documented.
Progress on A charge registered on 02 May 2002 via Charge ID 90147932 with Union Bank Of India was fully satisfied on 17 Sep 2013. was documented.
The activity A charge registered on 02 May 2002 via Charge ID 90143905 with Union Bank Of India was fully satisfied on 17 Sep 2013. was completed.
An independent Data Safety Monitoring Board (DSMB) recommended that Titan Pharmaceuticals’ Phase I/II trial of its ropinirole implant for Parkinson’s disease continue with a second cohort of patients. However, the company has decided to temporarily halt the study and focus on another asset..
The CIN of Titan Pharma (India ) Private Limited is U24234MH2001PTC133316.
Titan Pharma (India ) Private Limited is headquartered at 210Awing,Kanarabusinesscentre,Behindeverestgradenbuilding,Laxminagar,Ghatkopar, (East),, Mumbai, Maharashtra, 400075.
Titan Pharma (India ) Private Limited was incorporated on 10 September 2001.
The current directors of Titan Pharma (India ) Private Limited are
The primary industry of Titan Pharma (India ) Private Limited is Trade.
Titan Pharma (India ) Private Limited is unlisted.
The authorized capital of Titan Pharma (India ) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.38 M.
The compliance status of Titan Pharma (India ) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX